Last Posted: Apr 18, 2020
- Broad Host Range of SARS-CoV-2 Predicted by Comparative and Structural Analysis of ACE2 in Vertebrates
J Damas, et al, BIORXIV, April 18, 2020 - The landscape of pharmacogenetic testing in a US managed care population.
Anderson Heather D et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Apr - CoV Genome Tracker: tracing genomic footprints of Covid-19 pandemic
S Akhter et al, BIORXIV, April 15, 2020 - Detection rates and residual risk for a postnatal diagnosis of an atypical chromosome aberration following first trimester combined screening.
Iwarsson Erik et al. Prenatal diagnosis 2020 Apr - Genetic mosaicism in haemophilia: A practical review to help evaluate the risk of transmitting the disease.
Lannoy Nathalie et al. Haemophilia : the official journal of the World Federation of Hemophilia 2020 Apr - NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Daly Mary B et al. Journal of the National Comprehensive Cancer Network : JNCCN 2020 18(4) 380-391 - Participatory Genomic Testing Can Effectively Disseminate Cardiovascular Pharmacogenomics Concepts within Federally Qualified Health Centers: A Feasibility Study.
Johnson Amber et al. Ethnicity & disease 2020 30(Suppl 1) 167-176 - Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen.
Chan Carmen W H et al. Journal of cancer research and clinical oncology 2020 Apr - Survey of physicians' views on the clinical implementation of pharmacogenomics-based personalized therapy.
Kim Woo-Young et al. Translational and clinical pharmacology 2020 Mar 28(1) 34-42 - The clinical and laboratory investigation of dysbetalipoproteinemia.
Boot Christopher S et al. Critical reviews in clinical laboratory sciences 2020 Apr 1-12
.jpg)
No hay comentarios:
Publicar un comentario